MAP4 acts as an oncogene and prognostic marker and affects radioresistance by mediating epithelial-mesenchymal transition in lung adenocarcinoma.

Authors:
Xia X; Ge Y; Ge F; Gu P; Liu Y and 2 more

Journal:
J Cancer Res Clin Oncol

Publication Year: 2024

DOI:
10.1007/s00432-024-05614-8

PMCID:
PMC10858930

PMID:
38341398

Journal Information

Full Title: J Cancer Res Clin Oncol

Abbreviation: J Cancer Res Clin Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Competing interestsThe authors declare no competing interests. Conflict of interestNo potential conflict of interest in the subject matter is discussed in this manuscript. Ethics approval and consent to participateThis study has been approved by Nantong Tumor Hospital, and this study was conducted in accordance with the Declaration of Helsinki. Competing interests The authors declare no competing interests. Conflict of interest No potential conflict of interest in the subject matter is discussed in this manuscript."

Evidence found in paper:

"Funding This work was supported by the Nantong Science and Technology Bureau (JC2021151), Nantong Municipal Health Commission (MS2022048) and Huaian Science and Technology Project (HAB202138)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025